EMBL/QIMR Berghofer - Expression of Interest

EMBL Australia Partner Laboratory Group Leader in ‘Host Pathogen Interactions’ hosted at QIMR Berghofer

Expressions of interest are invited from suitably qualified scientists wishing to develop their scientific research career. This EMBL Australia Group Leader position is hosted within the Infectious Diseases Program at the QIMR Berghofer Medical Research Institute, Brisbane, Australia.

Benefits

  • Dedicated research leader position as an independent laboratory head, position entitled ‘QIMR Berghofer Team Head’ and EMBL Australia Group Leader.
  • Provision of core research funding and personalised support (e.g. grants administration)
  • Critical mass of outstanding researchers within an excellent, nurturing scientific environment, including mentoring from senior researchers
  • The opportunity to foster excellence and deliver leadership in a range of medical research projects and to supervise students.
  • State-of-the-art research facilities including PC3 laboratories and related infrastructure
  • Access to EMBL Australia development activities (e.g. scientific retreats, reviews, selection panels and student programs)

QIMR Berghofer Medical Research Institute

QIMR Berghofer has a long history in the study of infectious diseases since it was founded over 70 years ago. Today the Institute has diverse research activities (including cancer, mental health and chronic disorders), all underpinned by great strengths in immunology, cell and molecular biology, population health, genetics and bio-computing. For more information visit www.qimrberghofer.edu.au.

The laboratories that contribute to QIMR Berghofer’s Infectious Diseases Program study how a range of important pathogenic organisms cause illness, search for better ways to diagnose and treat them, and develop vaccines to prevent infections. A major emphasis is on infections that disproportionately affect people living in the developing world and tropical regions. Pathogens studied include mosquito-borne viruses, bacteria, parasites, such as intestinal protozoa, the malaria parasite and scabies, as well as viruses, such as human immunodeficiency virus (HIV), cytomegalovirus, and Epstein-Barr virus.

The Program continues to focus on strong collaborations between clinicians and researchers from both within QIMR Berghofer and across other institutes, the Herston Health Campus, which is one of the largest health campuses in Australia, as well as working with pharmaceutical companies to develop patented therapeutic technologies that improve the health of many.

The EMBL Australia Partner Laboratory Network

Australia was the first Associate Member of the European Molecular Biology Laboratory (EMBL). EMBL is an international research organisation that fosters excellence by providing a highly collaborative environment that benefits the research of all its scientists, whether at graduate, post-doctoral or group leader level. A key initiative of the associate membership is the EMBL Australia Partner Laboratory Network, a partnership of Australian research institutions which provide long-term funded, research-only positions allowing early to mid-career researchers to pursue ambitious research programs. QIMR Berghofer Medical Research Institution recently established a new node of the Partner Laboratory Network. For more information about EMBL Australia visit www.emblaustralia.org.

The position

We are seeking a top quality researcher to join our Infectious Diseases Program with a particular interest in host pathogen interactions. It is anticipated that the successful researcher will find strong internal collaborations, particularly with the immunology teams that have strengths in preclinical and clinical immunology.

The successful applicant will also participate in the collegial, collaborative culture of the EMBL Australia Partner Laboratory Network. The candidate will actively support the development of the network by participating in the various programs aimed at internationalizing research conducted in Australia through linking activities with EMBL.

Remuneration

Market competitive remuneration package will be negotiated with the successful candidate, including highly attractive salary packaging options.

Additional benefits

  • Access to the newly developed ‘Herston Imaging Research Facility’ (HIRF), including three key instruments: PRISMA 3T MRI, fully integrated PET-MRI, and PET-CT
  • Extensive scientific support services, including a large animal house
  • Shared campus with clinicians (Royal Brisbane and Women’s Hospital)
  • Translational research potential, including onsite TGA-licensed GMP cellular therapy facility
  • Clinical trial support and linkage to a QIMR Berghofer-owned clinical trial company (QPharm)

QIMR Berghofer is committed to gender equality in the workplace and strongly encourages applications from women. The Institute is also a leader in supporting female researchers in the workplace and has established a scheme of support programs designed to encourage women to remain in the workforce. These include generous paid parental leave, targeted financial assistance upon return, childcare assistance and parenting rooms.

QIMR Berghofer also provides attractive benefits and excellent support to maintain a healthy work/life balance and offers generous remuneration benefits, including four weeks’ annual leave (i.e. paid vacation) per year, highly attractive salary packaging options and assistance with visa and relocation expenses.

Contract term: The appointment will be for a period of five (5) years with the possibility of extension for an additional four (4) years.

Commencement date: Anticipated commencement is early 2018 or as otherwise agreed.

To apply please send a cover letter, full curriculum vitae and a concise statement summarising your research interests (current and future) to Professor Frank Gannon, QIMR Director and CEO, at: newrecruits@qimrberghofer.edu.au
Applications will be accepted until midnight 7 August 2017 Australian Eastern Standard Time.
Interviews will be held in Brisbane, Australia during the week commencing 25 September 2017.